Albuterol Sulfate; Ipratropium Bromide Patent Expiration
Albuterol Sulfate; Ipratropium Bromide was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Albuterol Sulfate; Ipratropium Bromide Patents
Given below is the list of patents protecting Albuterol Sulfate; Ipratropium Bromide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Combivent | US5603918 | Aerosol composition of a salt of ipratropium and a salt of albuterol |
Jun 09, 2015
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US5472143 | Atomising nozzle and filter and spray generation device |
Sep 29, 2013
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US5497944 | Atomising devices and methods |
Mar 12, 2013
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US5662271 | Atomizing devices and methods |
Sep 02, 2014
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US5911851 | Atomizing nozzle and filter and spray generating device |
Sep 29, 2013
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US5964416 | Device for producing high pressure in a fluid in miniature |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6007676 | Atomizing nozzle and filter and spray generating device |
Sep 29, 2013
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6149054 | Mechanical counter for a metering apparatus |
Dec 19, 2016
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6176442 | Device for mounting a component exposed to a pressurized fluid |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6453795 | Locking mechanism for a spring-actuated device |
Dec 05, 2016
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6503362 | Atomizing nozzle an filter and spray generating device |
Sep 29, 2013
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6726124 | Device for producing high pressure in a fluid in miniature |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6846413 | Microstructured filter |
Aug 28, 2018
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6977042 | Microstructured filter |
Aug 28, 2018
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US6988496 | Cartridge for a liquid |
Feb 23, 2020
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US7104470 | Device for producing high pressure in a fluid in miniature |
Oct 04, 2016
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US7246615 | Atomising nozzle and filter and spray generating device |
May 31, 2016
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US7284474 | Piston-pumping system having o-ring seal properties | Aug 26, 2024 | Boehringer Ingelheim |
Combivent Respimat | US7396341 | Blocking device for a locking stressing mechanism having a spring-actuated output drive device | Oct 10, 2026 | Boehringer Ingelheim |
Combivent Respimat | US7802568 | Cartridge for a liquid |
Feb 26, 2019
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US7837235 | Device for clamping a fluidic component | Mar 13, 2028 | Boehringer Ingelheim |
Combivent Respimat | US7896264 | Microstructured high pressure nozzle with built-in filter function | May 26, 2025 | Boehringer Ingelheim |
Combivent Respimat | US7988001 | Container provided with a pressure equalization opening |
Aug 04, 2021
(Expired) | Boehringer Ingelheim |
Combivent Respimat | US8733341 | Atomizer and method of atomizing fluid with a nozzle rinsing mechanism | Oct 16, 2030 | Boehringer Ingelheim |
Combivent Respimat | US9027967 | Device for clamping a fluidic component | Mar 31, 2027 | Boehringer Ingelheim |
Duoneb | US6632842 | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
Dec 28, 2021
(Expired) | Mylan Speciality Lp |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Albuterol Sulfate; Ipratropium Bromide Generics
Several generic applications have been filed for Albuterol Sulfate; Ipratropium Bromide. The first generic version for Albuterol Sulfate; Ipratropium Bromide was by Fosun Pharma Usa Inc and was approved on Dec 21, 2006. And the latest generic version is by Luoxin Aurovitas Pharma Chengdu Co Ltd and was approved on Jul 8, 2020.
Given below is the list of companies who have filed for Albuterol Sulfate; Ipratropium Bromide generic.
1. CIPLA
Cipla Ltd has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Cipla.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Prescription | INHALATION | AN | Dec 31, 2007 |
2. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Discontinued | INHALATION | N/A | Dec 31, 2007 |
3. APOTEX INC
Apotex Inc has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Apotex Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Discontinued | INHALATION | N/A | Dec 31, 2007 |
4. LUOXIN AUROVITAS
Luoxin Aurovitas Pharma Chengdu Co Ltd has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Luoxin Aurovitas.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Discontinued | INHALATION | N/A | Jul 8, 2020 |
5. FOSUN PHARMA
Fosun Pharma Usa Inc has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Fosun Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Discontinued | INHALATION | N/A | Dec 21, 2006 |
6. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Sun Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Prescription | INHALATION | AN | Aug 7, 2017 |
7. NEPHRON
Nephron Pharmaceuticals Corp has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Nephron.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017%
(reference standard) | solution | Prescription | INHALATION | AN | Dec 31, 2007 |
8. RITEDOSE CORP
The Ritedose Corp has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Ritedose Corp.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Prescription | INHALATION | AN | Oct 1, 2012 |
9. WATSON LABS TEVA
Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Albuterol Sulfate; Ipratropium Bromide. This eq 0.083% base;0.017% version comes by the name ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.083% BASE; 0.017% | solution | Discontinued | INHALATION | N/A | Dec 31, 2007 |